PMID: 2200430Jan 1, 1990Paper

Enantiomer-specific pharmacokinetics

Acta Pharmaceutica Nordica
G T Tucker

Abstract

No abstract listed.

References

Jan 1, 1979·European Journal of Drug Metabolism and Pharmacokinetics·S CacciaP De Ponte
Jul 1, 1978·British Journal of Clinical Pharmacology·C Aps, F Reynolds
Apr 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·A Yacobi, G Levy
Oct 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·T D BjornssonT F Blaschke
Aug 12, 1976·The New England Journal of Medicine·R A O'Reilly
Feb 1, 1988·Journal of Cardiovascular Pharmacology·A J BlockE R Smith
Jan 1, 1989·British Journal of Clinical Pharmacology·L BorgströmJ Paulson
May 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J M MayerB Testa
Aug 1, 1987·The Journal of Pharmacy and Pharmacology·H H Thijssen, L G Baars
Jan 1, 1988·Biochemical Pharmacology·T WalleT E Gaffney
May 1, 1988·The Journal of Pharmacy and Pharmacology·I TamaiA Tsuji
Mar 1, 1986·British Journal of Clinical Pharmacology·I A ChoonaraB K Park
Feb 1, 1986·British Journal of Clinical Pharmacology·A H ThomsonW S Hillis
Nov 1, 1988·British Journal of Pharmacology·H H ThijssenH T Vervoort-Peters
Dec 1, 1988·British Journal of Clinical Pharmacology·A M EvansA A Somogyi
Jan 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·F Jamali
May 1, 1988·British Journal of Clinical Pharmacology·T S GillM Rowland
Jun 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·J SchüttlerL B Sheiner
May 1, 1986·British Journal of Clinical Pharmacology·O Grech-BelangerM Gilbert
Jan 1, 1986·European Journal of Clinical Pharmacology·H H ThijssenL G Baars
Oct 1, 1986·Biochemical Pharmacology·K WilliamsA Duffield
Aug 1, 1986·Journal of Pharmacokinetics and Biopharmaceutics·K M GiacominiT F Blaschke
Oct 1, 1985·Drugs·K Williams, E Lee
May 1, 1985·British Journal of Clinical Pharmacology·E J LeeD Champion
Nov 1, 1985·The Journal of Clinical Investigation·P H Hsyu, K M Giacomini
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Jun 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·A Yacobi, G Levy
Apr 8, 1972·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·A Breckenridge, M L Orme
Apr 13, 1973·Nature·D N WadeJ L Morris
Jun 1, 1974·The Journal of Clinical Investigation·R J LewisW Schary
Jan 1, 1969·Annual Review of Pharmacology·F P Luduena
Jan 1, 1984·European Journal of Clinical Pharmacology·E J Ariëns
Dec 1, 1983·British Journal of Clinical Pharmacology·C BanfieldM Rowland
Apr 1, 1984·British Journal of Clinical Pharmacology·M EichelbaumB Vogelgesang

❮ Previous
Next ❯

Citations

Jan 1, 1993·Chirality·A S GrossM Eichelbaum
Jan 1, 1993·Chirality·S MenzelG Geisslinger
Jul 1, 1993·Journal of Clinical Pharmacology·D LalkaC L Cronenberger
Jan 1, 1993·European Journal of Clinical Pharmacology·A J McLachlanS E Tett
Apr 1, 1990·European Journal of Drug Metabolism and Pharmacokinetics·D B Campbell
Mar 3, 1995·Journal of Chromatography. a·Y Tokuma, H Noguchi
Nov 3, 1990·Lancet
Feb 23, 1996·Journal of Chromatography. B, Biomedical Applications·J OravcováW Lindner
Oct 1, 1994·Journal of Pharmaceutical and Biomedical Analysis·L SoltésP Szalay
Jul 1, 1994·Journal of Pharmaceutical and Biomedical Analysis·A Van OverbekeC Dewaele
Oct 1, 1995·Journal of Pharmaceutical and Biomedical Analysis·K M HöldR A Maes
Apr 30, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C Scarpignato
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Csilla Misl'anová, Milan Hutta
Jan 25, 2003·Journal of Biochemical and Biophysical Methods·Katharina M Rentsch
Apr 10, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Akimasa ShibukawaIrving W Wainer
Apr 10, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Akimasa ShibukawIrving W Wainer
Nov 8, 1996·Journal of Chromatography. B, Biomedical Applications·J DucharmeR Farinotti
May 10, 2000·International Journal of Pharmaceutics·F K Główka
Nov 4, 1998·Forensic Science International : Synergy·D JirovskýZ Stránský
Jan 5, 2002·Journal of Pharmaceutical and Biomedical Analysis·Takanori OhnishiMicheal E El Kommos
Mar 12, 2004·Journal of Pharmaceutical and Biomedical Analysis·Y F CuiM L Liu
Jun 1, 1997·Journal of Pharmaceutical and Biomedical Analysis·M E Rodriguez RosasT Nakagawa
Jan 30, 1999·Journal of Pharmaceutical and Biomedical Analysis·A ShibukawaT Nakagawa
Mar 7, 2000·Journal of Pharmaceutical and Biomedical Analysis·N A MohamedM E El Kommos
Jan 29, 2000·Journal of Veterinary Pharmacology and Therapeutics·M F LandoniP Lees
Jun 1, 1991·British Journal of Clinical Pharmacology·M S Lennard
Apr 1, 1992·British Journal of Clinical Pharmacology·M P KnadlerS D Hall
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·M F Landoni, P Lees
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·T N Calvey
Dec 1, 1990·The Journal of Pharmacy and Pharmacology·L G BaarsH H Thijssen
Jul 18, 2001·Biological & Pharmaceutical Bulletin·H EndoS Higuchi
Aug 22, 2007·Drug Metabolism and Drug Interactions·Andrew J Hutt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.